Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Description
In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Prof Dennis Lau
Postural Orthostatic Tachycardia Syndrome – What You Need to Know
Prof Tony Attwood
Autism Assessment in the GP Setting
Prof Brendon Yee, A/Prof Ralph Audehm
Obstructive Sleep Apnoea – Practical Updates
Clinical A/Prof Greg Katsoulotos
Asthma Cases
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
